I am delighted to announce the Agos Pharma Bridge to Europe™ service which enables pharma and biotech companies to develop and market products in Europe, even if they have no presence here.
There are differences as well as similarities between regulatory requirements in Europe and other territories and many European processes will require a presence in the EEA.
Agos Pharma was established by dedicated healthcare professionals who have spent a lifetime in bringing medicines to patients in Regulatory Authority, Small Pharma, Big Pharma, Start Up, Biotech and CRO environments.
From our bases in the UK, Ireland and the USA, we can act as your Bridge to Europe™. Our CEO will be visiting clients on the East and West Coast of the USA in late February and early March. He would be delighted to meet you and discuss how Agos Pharma can help you develop and market products in Europe.
Take a look at our website for more resources and information: www.agospharma.com